focus -WSS

focus

author：Wikipedia 2025-08-24 19:11:05 - browse：25358

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Extensive review finds private equity owners jack up cost of care

leisure time

WSS

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Delta passengers in Vegas fall sick while waiting on flight in triple

What health policies could hitch a ride on a spending bill?

Healthy food access boosts outcomes in two studies

White House drug czar issues call for 'recovery

After decades in use, heart stents finally beat placebo

Wikipedia

focus

hotspot

At least 13 dead in Texas as scorching temps continue

Judge denies Trump's request for new trial in E. Jean Carroll case

Cancer drug shortages should be causing more outrage

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Supreme Court strikes down use of affirmative action

How a Boston hospital is priming medical residents to use GPT

Bright Health sells Medicare Advantage business to Molina

After a decade, new Gardasil ad campaign gets it (mostly) right

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

NIH chief: government has fallen behind pharma on clinical trials

focus

Weight loss drugs should be covered by insurers, AMA says

After decades in use, heart stents finally beat placebo

In rare move, senator releases unverified FBI source report alleging Biden bribe

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

What is STAT's opinion section for?

Stanford president’s abrupt resignation sparks debate

leisure time

entertainment

hotspot

focus